CHAIN features in Genetic Engineering & Biotechnology News (GEN)

”An expansive view of design has been adopted at CHAIN Biotechnology, which is developing new therapeutics based on living microbes where the “bug is the drug.” These drugs are based on a single strain of Clostridium bacteria that is naturally found in the gut, but which has been deliberately engineered to carry a therapeutic payload, such as custom metabolites, enzymes, or peptides.”

https://www.genengnews.com/insights/synthetic-biology-seizes-new-ground-in-healthcare/